| Huynh H, Ngo VC, Koong HN, et al.
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC). [JOURNAL ARTICLE]
J Hepatol 2009 Oct 28.
Abstract | Full Citation | Find Related Articles |
| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Sep; 31(7):463-93.
Abstract | Full Citation |
| Hong DS, Sebti SM, Newman RA, et al.
Phase I Trial of a Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Advanced Malignancies. [JOURNAL ARTICLE]
Clin Cancer Res 2009 Nov 10.
Abstract | Full Citation |
| Kim HJ, Jung MH, Kim H, et al.
Synthesis and antiproliferative activity of pyrrolo[3,2-b]pyridine derivatives against melanoma. [JOURNAL ARTICLE]
Bioorg Med Chem Lett 2009 Aug 6.
Abstract | Full Citation |
| Ide S, Soda H, Hakariya T, et al.
Interstitial pneumonia probably associated with sorafenib treatment: An alert of an adverse event. [JOURNAL ARTICLE]
Lung Cancer 2009 Nov 6.
Abstract | Full Citation |
| Akita H
[Molecular targeted drugs in the developmental stage: 2) Various molecular targets and therapeutic agents under investigation] [Journal Article, Review]
Nippon Naika Gakkai Zasshi 2009 Aug 10; 98(8):1894-900.
Full Citation | Find Related Articles |
| Sibaud V, Delord J, Chevreau C
Sorafenib-induced hand-foot skin reaction: a Koebner phenomenon? [JOURNAL ARTICLE]
Target Oncol 2009 Nov 7.
Abstract | Full Citation | Find Related Articles |
| Sonpavde G, Hutson TE
Novel antiangiogenic agents in the treatment of refractory renal cell carcinoma. [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S29-36.
Abstract | Full Citation | Find Related Articles |
| Chung EK, Stadler WM
Vascular endothelial growth factor pathway-targeted therapy as initial systemic treatment of patients with renal cancer. [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S22-8.
Abstract | Full Citation | Find Related Articles |
| Bukowski RM
What role do combinations of interferon and targeted agents play in the first-line therapy of metastatic renal cell carcinoma? [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S14-21.
Abstract | Full Citation | Find Related Articles |
   |
